Overview
Escherichia coli O157 infections, particularly those caused by enterohemorrhagic E. coli O157:H7, can lead to severe gastrointestinal symptoms including bloody diarrhea, hemorrhagic colitis, and in some cases, hemolytic uremic syndrome (HUS). 1Diagnosis
Serological Testing: Detection of serum antibodies against E. coli O157 lipopolysaccharide using rapid immunoblotting methods can aid in diagnosis. (Time-efficient procedure completed in one day) 2
Stool Culture: Isolation of E. coli O157 from stool samples remains the gold standard for confirming infection.
Clinical Presentation: Bloody diarrhea, abdominal pain, and vomiting are key clinical indicators requiring further diagnostic testing.Management
Supportive Care: Fluid resuscitation and electrolyte management are critical, especially in preventing dehydration and maintaining hemodynamic stability.
Avoid Unnecessary Antibiotics: Antibiotics are generally not recommended as they may increase the risk of developing HUS. 1
Monitor for Complications: Close monitoring for signs of hemolytic uremic syndrome, particularly in children and elderly patients.Special Populations
Pediatrics: Children are particularly vulnerable to developing HUS following E. coli O157 infection. 1
Elderly: Older adults may experience more severe complications due to underlying comorbidities and decreased physiological reserve. 1Key Recommendations
Use Rapid Serological Testing for early detection of E. coli O157 antibodies in suspected cases. (Evidence: Moderate) 2
Prioritize Supportive Care including hydration and electrolyte management to prevent complications. (Evidence: Expert opinion) 1
Avoid Routine Antibiotic Therapy in uncomplicated cases to reduce HUS risk. (Evidence: Moderate) 1References
1 La Ragione RM, Ahmed NM, Best A, Clifford D, Weyer U, Cooley WA et al.. Colonization of 8-week-old conventionally reared goats by Escherichia coli O157 : H7 after oral inoculation. Journal of medical microbiology 2005. link
2 Chart H, Montgomery S, Rowe B. A rapid immunoblotting procedure for detecting serum antibodies to the lipopolysaccharide of Escherichia coli O157. Letters in applied microbiology 1994. link